This stock is an absolute monster. Up 336% YTD with plenty more catalysts coming down the pipe. They raised the guidance nearly $60,000,000 and considering how conservative this company has been has a chance to beat that. With more of their lung data coming out shortly, a possible UK approval, and esmo at the end of October this thing is going to continue to fly. B/o q1 2027 or they don’t sell and keep going up.
CryptoAlerta — análise de criptomoedas e mercado em tempo real